Get started
UNITEDHEALTH GROUP INCUNITEDHEALTH GROUP INCUNITEDHEALTH GROUP INC

UNITEDHEALTH GROUP INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

UNHCL trade ideas

Where does the tumble stop for $UNHUNH has been in a free fall been absolute chaos for..reasons. I see a possible Shark. Sharks can complete at the 886 or the 113. This happens to be around the 236 and 382 of the Macro fib retracement. We also have the 200 Monthly SMA. So where does it stop tumbling? The 236, the 382 or the 200 Monthly SMA? I am betting it goes to the 236 and bounces sometime around earnings. Notice that trendline that goes back to 1998 that acts as support. I am betting it bounces around where the trendline and 236 intersect sometime around the next earnings. That's a good spot to go long.
NYSE:UNH
by HotsauceShoTYME
Now what do you do with UNH ?For me, it is a screaming buy. Hear me out. This was in my watch list for a while but I never get a chance to go long as the price keeps climbing up or my funds were tied up with other shares/ETFs, etc. A 50% fall from the peak but what is more important is the parabolic move down, almost 5 straight weeks of 90 degrees plunge down. The sell down seems pretty serious and by any metric you used, it is way oversold and begs for a reversal. However, on the daily chart, it is still RED which means the selling is not done yet and we could probably see more sell down days ahead to 196-279 price level. So, I will be watching it closely this time and be ready to nibble some when it falls further. Healthcare stocks seem to be battered in this sector rotation round so get ready your ammunition , the reversal could come sooner than later........
NYSE:UNHLong
by dchua1969
UNH next strong Support $286As of May 13, 2025, UnitedHealth Group (UNH) stock is experiencing significant volatility due to recent corporate developments: 📉 Current Stock Performance Price: Around $337.02 in premarket trading, down approximately 11% 1. Previous Close: $380.72 2. 📰 Key News CEO Change: Andrew Witty has resigned as CEO for personal reasons. Stephen Hemsley, former CEO (2006–2017), has returned to the role. 2025 Guidance Suspended: UnitedHealth has suspended its 2025 financial outlook due to higher-than-expected Medicare Advantage costs and increased care activity 1. 📊 Analyst Outlook Consensus Rating: Moderate Buy based on 24 analyst ratings. Average Price Target: $596.86, suggesting a potential 56.77% upside from the previous close 2. Price Target Range: $490 to $700. Would you like a chart of UNH’s recent stock performance or a breakdown of analyst ratings over time?
NYSE:UNH
by Hobite
UnitedHealth: Reversal incoming?UnitedHealth: The UNH stock is undergoing a correction phase, with the possibility of further declines into the - support zone. This level is marked as a strong long-term buy opportunity for investors, and price recovery is expected from this zone. Should this correction unfold as anticipated, the stock could rally to and beyond, with potential targets at and in the longer term. Thank you for taking the time to read my analysis. I look forward to reading your thoughts. Best regards, Mattner
NYSE:UNHLong
by MattnerFuture
Not All Hype = Opportunity | UnitedHealth $UNH Analysis Lately, I’ve been seeing a lot of chatter about buying NYSE:UNH — UnitedHealth Group — as if it’s the “big opportunity” after the drop… But let’s keep it real — the chart isn’t confirming that yet. 👀 Take a close look 👇 Price completely broke structure from previous highs around $630. The recent drop was aggressive, and there's no clean retest or setup forming yet. Unlike NASDAQ:MSTR (MicroStrategy), which gave us a structured pullback and liquidity sweep, NYSE:UNH still looks like it has more downside to go. ⚠️ I’m not rushing in because the news or a rumor says “buy now.” I’d rather wait for a clearer structure, a lower low, and a reaction from a real demand zone — just like the example I marked on MicroStrategy. This is a great reminder: Let price tell you when it's time — not social media hype. For now, NYSE:UNH goes on the watchlist, not the buy list. 📉🧠
NYSE:UNHShort
by MoNi_MoN
UNH can start DCA investment Strategy. 18 May 2025 UnitedHealth Group (UNH) – Oversold & Attracting Insider Confidence UNH has recently drawn attention after its stock price dropped over 50% since mid-April 2025. Putting aside the fundamental and media noise, the technical analysis shows that the stock is heavily oversold. Last Friday, the stock rebounded over 6%, possibly driven by a strong show of confidence from insiders. Newly reinstated CEO Stephen Hemsley purchased approximately $25 million worth of UNH shares (86,700 shares at an average of $288.18). CFO John Rex also acquired $5 million, with directors Timothy Flynn and Kristen Gil making significant purchases as well. From a price action standpoint, the current level appears attractive for a Dollar-Cost Averaging (DCA) approach. However, I'm personally eyeing a potential deeper discount entry zone between $200–$220, which would offer an even more compelling long-term risk-reward setup. Strategy: Start small with DCA at current levels, but be patient for deeper dips for larger entries.
NYSE:UNHLong
by probabilityta
UnitedHealth Group Stock Chart Fibonacci Analysis 051625Trading Idea 1) Find a FIBO slingshot 2) Check FIBO 61.80% level 3) Entry Point > 287/61.80% Chart time frame: D A) 15 min(1W-3M) B) 1 hr(3M-6M) C) 4 hr(6M-1year) D) 1 day(1-3years) Stock progress: A A) Keep rising over 61.80% resistance B) 61.80% resistance C) 61.80% support D) Hit the bottom E) Hit the top Stocks rise as they rise from support and fall from resistance. Our goal is to find a low support point and enter. It can be referred to as buying at the pullback point. The pullback point can be found with a Fibonacci extension of 61.80%. This is a step to find entry level. 1) Find a triangle (Fibonacci Speed Fan Line) that connects the high (resistance) and low (support) points of the stock in progress, where it is continuously expressed as a Slingshot, 2) and create a Fibonacci extension level for the first rising wave from the start point of slingshot pattern. When the current price goes over 61.80% level , that can be a good entry point, especially if the SMA 100 and 200 curves are gathered together at 61.80%, it is a very good entry point. As a great help, tradingview provides these Fibonacci speed fan lines and extension levels with ease. So if you use the Fibonacci fan line, the extension level, and the SMA 100/200 curve well, you can find an entry point for the stock market. At least you have to enter at this low point to avoid trading failure, and if you are skilled at entering this low point, with fibonacci6180 technique, your reading skill to chart will be greatly improved. If you want to do day trading, please set the time frame to 5 minutes or 15 minutes, and you will see many of the low point of rising stocks. If want to prefer long term range trading, you can set the time frame to 1 hr or 1 day.
NYSE:UNH
by fibonacci6180
UnitedHealth Group faces DOJ criminal probeUnitedHealth Group faces DOJ criminal probe amid stock turmoil. Will the gaps be filled? (and most importantly when) This situation shows the critical importance of compliance and transparency in the healthcare industry, especially for companies managing public funds. UnitedHealth Group is under a criminal investigation by the U.S. Department of Justice for potential Medicare fraud, as reported by the Wall Street Journal. This follows a civil inquiry earlier this year and a separate Senate investigation into the company's Medicare billing practices. The company's stock has experienced significant volatility, recently closing at $308.01, marking a 48% decline over the past month and a 40% drop year-over-year. Analysts have adjusted their outlooks accordingly, with Oppenheimer setting a price target of $400, KeyBanc at $450, and B of A Securities at $350. #trading #tradingcards #tradingstrategy #daytrading #swingtrading #stocktrading #optionstrading
NYSE:UNH
by Elias-Lo
Cash printing machine on saleFor all the hatred UNH gets, this company is looking like a buy after this huge sell off. We are approaching the golden ratio around $380. The company generates $100bn in revenue per quarter, hence why it’s a highly regarded cash printing machine. The bearishness may continue as we sit below the 200week MA. I have a worst case scenario of $300 where we have a strong weekly level of support. I think we’ll bottom closer to the mid $300s so I’ll be taking a nibble with a longer term view on this stock. Not financial advice
NYSE:UNHLong
by NoFOMO_
UNH Under Pressure – Below EMA 200 with Heavy Selling VolumeUNH (UnitedHealth) is showing clear bearish signs: Price has dropped below the EMA 200, a key long-term support level Recent sessions show strong selling volume, indicating institutional exit Trend is downward, with no bullish confirmation yet ⚠️ I stay cautious here — waiting for volume shift or price reclaim above EMA before considering a reversal. Until then, the bearish momentum stays active. Not financial advice – just my technical view. #UNH #StockAnalysis #BearishTrend #VolumeAnalysis #EMA200 #TechnicalTrading #HealthcareStocks
NYSE:UNH
by abdeljalillariam
$UNH Rinse & Repeat Round #2- Fundamentally it's undervalued for the quality blue chip company. My detailed analysis is on the older post I made earlier this year. I have attached that as a reference. - In my previous swing, I bought NYSE:UNH on a sell off @ 441 and sold @600 before earning as a de-risking strategy. I'm glad that it did work out. - I'm happy that NYSE:UNH is again trading at a discount and with compressed Earning multiple. This time I am buying it even lower than where I bought last time i.e 441 and I was happy with that price average. - Whereas I do believe that NYSE:UNH EPS is lowered but it is lowered slightly which doesn't warrant a big sell off like this. - I wanted to wait further before entering but I can't stop myself from buying this name NYSE:UNH at a price where I believe it's very undervalued. - Therefore, I have re-entered the NYSE:UNH and added it to my portfolio . I will consider adding further if selling pressure continues because I don't want to time the bottom. - But undecisive market and lumpy market, going with a defensive name like this is a no brainer.
NYSE:UNHLong
by bigbull037
2
UnitedHealth (UNH) Share Price PlummetsUnitedHealth (UNH) Share Price Plummets UnitedHealth shares crashed by nearly 23% yesterday after the healthcare giant reported weaker-than-expected Q1 2025 results: → Earnings per share: actual = $7.20, expected = $7.29 → Revenue: actual = $109.5bn, expected = $111.5bn Technical Analysis of UNH Share Chart As far back as a year ago, we highlighted key support around the $450 level. Yesterday’s negative news caused this support to once again demonstrate its strength by holding back further decline — but will it hold? Taking the price action marked on the chart as a base, we can establish the structure of a descending channel (shown in red), with the price gapping sharply lower into the bottom half of this channel — and yesterday’s candle high (marked with an arrow) suggests that the median line has turned into resistance. Yesterday’s candle closed near its lows, so it is reasonable to assume that bearish pressure may persist (with the aim of testing the lower boundary) — in which case, the $450 support zone, in place since early 2022, could be at risk. This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.
NYSE:UNH
by FXOpen
1
$UNH buy the fear or sell into narrative?- NYSE:UNH has gotten into trouble with bad headlines after bad headlines. - Recent DOJ probe led to 12% shaving in the stock price. - Could it be a buying opportunity or just a falling knife? - Are you afraid that NYSE:UNH could become NYSE:HUM 2.0? Let's talk about fundamentals! Year | 2024 | 2025 | 2026 | 2027 | 2028 GAAP EPS | 15.76. | 28.22 | 32.11 | 36.80 | 41.11 EPS growth% | -33.47% | 79.08% | 13.77% | 14.61% | 11.71% It appears that 2024/ Early 2025 was the year when EPS growth bottomed and would go from negative to positive back again. EPS growth is healthy double digit in mid teens. A fair forward p/e multiple for mid teen EPS growth should at least be 15 ( conservatively ) Year | 2024 | 2025 | 2026 | 2027 | 2028 Fair Stock Price (w/ forward p/e = 15 ) | $236 | $423 | $481 | $552 | $616 However, NYSE:UNH is a blue chip company and has a moat. Therefore, Investors will be willing to pay forward p/e of 20 once negative news subside. Year | 2024 | 2025 | 2026 | 2027 | 2028 Fair Stock Price (w/ forward p/e = 20 ) | $315 | $564 | $642 | $736 | $822.2 Final Take: I'm a buyer of NYSE:UNH < 450 will add more if it dips below 400 for the long term. Good quality companies don't usually buyers to get their skin into the game. Therefore, it's better to buy the fear than selling into narrative.
NYSE:UNHLong
by bigbull037
5